In the late 1800’s, the German psychiatrist Emil Kraepelin was unhappy with the primitive state of psychiatric diagnosis. So he set up shop at the Heidelberg Clinic and proceeded to study hundreds of patients longitudinally.
Read More
Dr. Baldassano, as the Director of the Bipolar Outpatient Clinic of U Penn, how many patients with bipolar disorder do you typically evaluate in a given week?
Read More
Suddenly, we all have a colleague who is prescribing Trileptal (oxcarbazepine) for bipolar disorder, and who is claiming to have fabulous success.
Read More
Topamax (topiramate), oddly enough, is a derivative of fructose. It is strange that one of the very few psychotropics to cause weight loss is closely related to sugar, but there you have it. It is only approved as adjunctive therapy for seizure treatment by the FDA.
Read More
Dr. Aiken is the Editor in Chief of The Carlat Psychiatry Report; director of the Mood Treatment Center in North Carolina, where he maintains a private practice combining medication and therapy along with evidence-based complementary and alternative treatments; and Assistant Professor NYU Langone Department of Psychiatry. He has worked as a research assistant at the NIMH and a sub-investigator on clinical trials, and conducts research on a shoestring budget out of his private practice. Follow him on Twitter and find him on LinkedIn.
_-The-Breakthrough-Antipsychotic-That-Could-Change-Everything.jpg?1729528747 "KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg")
